These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9742539)

  • 1. Salicylate toxicity masquerading as malignant hyperthermia.
    Candy JM; Morrison C; Paton RD; Logan RW; Lawson R
    Paediatr Anaesth; 1998; 8(5):421-3. PubMed ID: 9742539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperpyrexia--the difficulty of diagnosis.
    Jago RH; Payne MJ
    Anaesthesia; 1976 Sep; 31(7):955-6. PubMed ID: 970594
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant hyperpyrexia during anesthesia in childhood.
    Bloom DA; Fonkalsrud EW; Reynolds RC
    J Pediatr Surg; 1976 Apr; 11(2):185-90. PubMed ID: 1263056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia in anaesthesia.
    Isaacs H
    S Afr Med J; 1972 Sep; 46(37):1321. PubMed ID: 4637791
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for malignant hyperpyrexia.
    Bradley WG; Murchison D
    Br Med J; 1972 Oct; 4(5832):108-9. PubMed ID: 5077443
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of suspected malignant hyperpyrexia in an infant.
    Faust DK; Gergis SD; Sokoll MD
    Anesth Analg; 1979; 58(1):33-5. PubMed ID: 571220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine phosphokinase (CPK) levels in pregnancy: a case report and a discussion of the value of CPK levels in the prediction of possible malignant hyperpyrexia.
    Isherwood DM; Ridley J; Wilson J
    Br J Obstet Gynaecol; 1975 Apr; 82(4):346-9. PubMed ID: 1125158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarification needed regarding use of bismuth salicylate.
    Eenigenburg DL
    Pediatr Ann; 2009 Jul; 38(7):353; discussion 353. PubMed ID: 19685652
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for malignant hyperpyrexia.
    Ellis FR; Keaney NP; Harriman DG; Sumner DW; Kyei-Mensah K; Tyrrell JH; Hargreaves JB; Parikh RK; Mulrooney PL
    Br Med J; 1972 Sep; 3(5826):559-61. PubMed ID: 5069639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of post-anaesthetic hyperthermia with abnormal muscle characteristics: a case report.
    Kripke BJ; Blanck TJ; Sizemore DA; Comunale FL; Christiansen J; Gruener R
    Can Anaesth Soc J; 1983 May; 30(3 Pt 1):290-4. PubMed ID: 6336551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Central hyperthermia suspected of malignant hyperthermia in a patient undergoing radical neck clipping for cerebral aneurysm].
    Murakawa T; Sakai I; Matsuki A
    Masui; 2005 Jan; 54(1):49-53. PubMed ID: 15717469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative hyperthermia in a child with neuroblastoma.
    Mayhew JF
    Paediatr Anaesth; 2006 Aug; 16(8):890-1. PubMed ID: 16884475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phaeochromocytoma presenting as acute malignant hyperthermia--a diagnostic challenge.
    Allen GC; Rosenberg H
    Can J Anaesth; 1990 Jul; 37(5):593-5. PubMed ID: 2372861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative hyperpyrexia--keep an open mind.
    Crider B; Nightingale P; Hill AB
    Anesthesiology; 1986 Mar; 64(3):413. PubMed ID: 3954146
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Serum creatine phosphokinase and malignant hyperpyrexia.
    Ryan DW; Appleyard TN
    Br Med J; 1976 Jan; 1(6001):96. PubMed ID: 1244960
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin and salicylate in respiratory disease.
    Mitchell JE; Skypala I
    Rhinology; 2013 Sep; 51(3):195-205. PubMed ID: 23943725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant hyperthermia due to general anesthesia. Diagnosis and treatment].
    Böttger P; Doehn M; Horatz K; Kessler G
    Anasthesiol Intensivmed Prax; 1975; 10(1):13-6. PubMed ID: 1163751
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant hyperpyrexia in Australia and New Zealand.
    King JO; Denborough MA
    Med J Aust; 1973 Mar; 1(11):525-8. PubMed ID: 4699727
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Serum creatine phosphokinase and malignant hyperpyrexia.
    Ellis FR; Clarke IM; Modgill EM; Currie S; Harriman DG
    Br Med J; 1976 Mar; 1(6009):584. PubMed ID: 1260292
    [No Abstract]   [Full Text] [Related]  

  • 20. Markedly delayed postoperative malignant hyperthermia.
    Souliere CR; Weintraub SJ; Kirchner JC
    Arch Otolaryngol Head Neck Surg; 1986 May; 112(5):564-6. PubMed ID: 3954899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.